GLP-1 agonists work by mimicking the effects of this hormone, resulting in several beneficial metabolic actions: Stimulate insulin secretion from the pancreas in response to meals Suppress appetite by acting on appetite centers in the brain Slow gastric emptying , which helps prolong satiety after eating Reduce glucagon secretion , helping to lower blood sugar levels Together, these effects make GLP-1 agonists an effective tool not only for diabetes management but also for sustainable, medically supervised weight loss
GLP-1 medications may be appropriate for certain patients when prescribed and monitored by a licensed healthcare provider
Protein kinase C and fatty acid transport protein 4 (FATP4) [144] play an important role in the increase of GLP-1 secretion and improvement in glycemic tolerance caused by oleic acid (OA), both in vivo and in vitro [145]
If and when retatrutide hits the market, it could give people with diabetes another option
These firms are exploring novel targets, combinations, and therapeutic modalities
.jpg)
